• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和验证与肝细胞癌预后和肿瘤免疫相关的坏死性凋亡相关基因特征。

Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma.

机构信息

Department of Gastrointestinal Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

出版信息

Medicine (Baltimore). 2022 Sep 9;101(36):e30219. doi: 10.1097/MD.0000000000030219.

DOI:10.1097/MD.0000000000030219
PMID:36086716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10980426/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is the sixth most common cancer, which is characterized by complicated etiology, excessive heterogeneity, and poor prognosis. Necroptosis is a new kind of programmed cell death, which is intently associated with the occurrence and development of tumors. Although researchers have had a deep understanding of necroptosis in recent years, the expression level of necroptosis-related genes in HCC and its relationship with the survival time of HCC patients are not clear.

METHODS

According to the expression of necroptosis-related genes and the survival of HCC patients, HCC patients in the TCGA database were divided into 2 groups that were relatively independent of each other. The genes related to the survival time of HCC patients were screened from the 2 groups of differentially expressed genes. By using the Least Absolute Shrinkage and Selection Operator Cox regression analysis, the optimal λ value was obtained, and the 10-gene signature model was established.

RESULTS

According to the median risk score of the TCGA cohort, HCC patients were averagely divided into high- and low-risk groups. Compared with the low-risk group, the death toll of the high-risk group was relatively higher and the survival time was relatively shorter. Principal component analysis and t-distributed stochastic neighbor embedding analysis showed that there was a significant separation between high- and low-risk groups. Through Kaplan-Meier analysis, it was found that the survival time of HCC patients in the high-risk group was significantly shorter than that in the low-risk group. Through receiver operating characteristic analysis, it was found that the sensitivity and specificity of the model were good. We also make a comprehensive analysis of the international cancer genome consortium database as a verification queue and prove the reliability of the 10-gene signature model. Gene Ontolog, Kyoto Encyclopedia of Genes and Genomes, and single-sample gene set enrichment analysis showed that many biological processes and pathways related to immunity had been enriched, and the antitumor immune function was weakened in the high-risk population.

CONCLUSION

The risk score can be considered as an independent prognostic factor to predict the prognosis of patients with HCC, and necroptosis-related genes are also closely related to tumor immune function.

摘要

背景

肝细胞癌(HCC)是第六大常见癌症,其具有复杂的病因、高度异质性和预后不良的特点。细胞坏死性凋亡是一种新的程序性细胞死亡方式,与肿瘤的发生和发展密切相关。尽管近年来研究人员对细胞坏死性凋亡有了更深入的了解,但 HCC 中细胞坏死性凋亡相关基因的表达水平及其与 HCC 患者生存时间的关系尚不清楚。

方法

根据 TCGA 数据库中 HCC 患者的细胞坏死性凋亡相关基因表达和生存情况,将患者分为两组,两组之间相对独立。从两组差异表达基因中筛选与 HCC 患者生存时间相关的基因。通过最小绝对收缩和选择算子 Cox 回归分析,得到最优 λ 值,并建立 10 基因特征模型。

结果

根据 TCGA 队列的中位数风险评分,将 HCC 患者平均分为高低风险组。与低风险组相比,高风险组的死亡人数相对较高,生存时间相对较短。主成分分析和 t 分布随机邻域嵌入分析表明,高低风险组之间存在显著分离。通过 Kaplan-Meier 分析发现,高风险组 HCC 患者的生存时间明显短于低风险组。通过接受者操作特征分析发现,该模型的敏感性和特异性均较好。我们还对国际癌症基因组联盟数据库进行了综合分析作为验证队列,并证明了 10 基因特征模型的可靠性。基因本体论、京都基因与基因组百科全书和单样本基因集富集分析表明,许多与免疫相关的生物学过程和途径被富集,高风险人群的抗肿瘤免疫功能减弱。

结论

风险评分可以被认为是一个独立的预后因素,可预测 HCC 患者的预后,细胞坏死性凋亡相关基因也与肿瘤免疫功能密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/c2ab4afd69be/medi-101-e30219-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/51f00a973384/medi-101-e30219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/385578108ef8/medi-101-e30219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/83392ca69efd/medi-101-e30219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/f8dc05eabc4b/medi-101-e30219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/2641b7db1f55/medi-101-e30219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/d571df9d5b99/medi-101-e30219-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/6cbc23b5694a/medi-101-e30219-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/c2ab4afd69be/medi-101-e30219-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/51f00a973384/medi-101-e30219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/385578108ef8/medi-101-e30219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/83392ca69efd/medi-101-e30219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/f8dc05eabc4b/medi-101-e30219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/2641b7db1f55/medi-101-e30219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/d571df9d5b99/medi-101-e30219-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/6cbc23b5694a/medi-101-e30219-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a21/10980426/c2ab4afd69be/medi-101-e30219-g008.jpg

相似文献

1
Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma.鉴定和验证与肝细胞癌预后和肿瘤免疫相关的坏死性凋亡相关基因特征。
Medicine (Baltimore). 2022 Sep 9;101(36):e30219. doi: 10.1097/MD.0000000000030219.
2
Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.铜死亡相关特征可预测肝细胞癌的预后、肿瘤微环境和药物敏感性。
J Immunol Res. 2022 Nov 16;2022:3393027. doi: 10.1155/2022/3393027. eCollection 2022.
3
A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.一个与细胞坏死相关的基因特征可预测皮肤黑色素瘤的预后。
Dis Markers. 2022 Nov 16;2022:8232024. doi: 10.1155/2022/8232024. eCollection 2022.
4
Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.基于凋亡相关基因挖掘亚洲肝细胞癌患者的预后标志物。
BMC Cancer. 2021 Feb 18;21(1):175. doi: 10.1186/s12885-021-07886-6.
5
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.焦亡相关基因特征可预测肝细胞癌的预后,并提示免疫活性。
Mol Med. 2022 Feb 5;28(1):16. doi: 10.1186/s10020-022-00445-0.
6
Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.构建与坏死性凋亡相关的长链非编码RNA特征以预测肝细胞癌的预后和免疫反应
Front Mol Biosci. 2022 Jul 13;9:937979. doi: 10.3389/fmolb.2022.937979. eCollection 2022.
7
Development and Validation of a Novel Circadian Rhythm-Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma.开发和验证一种新型与昼夜节律相关的特征签名,以预测肝细胞癌患者的预后。
Biomed Res Int. 2022 Aug 12;2022:4263261. doi: 10.1155/2022/4263261. eCollection 2022.
8
Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.鉴定免疫浸润相关基因作为肝细胞癌的预后指标。
BMC Cancer. 2022 May 5;22(1):496. doi: 10.1186/s12885-022-09587-0.
9
A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.一个与坏死性凋亡相关的基因特征,可用于预测肝细胞癌的预后、免疫图谱和药物敏感性。
Cancer Med. 2022 Dec;11(24):5079-5096. doi: 10.1002/cam4.4812. Epub 2022 May 13.
10
A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.一种新型与氧化磷酸化相关的基因特征可用于预测肝细胞癌患者的预后。
Dis Markers. 2022 Sep 5;2022:3594901. doi: 10.1155/2022/3594901. eCollection 2022.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.免疫相关基因预后模型在胃腺癌中的建立和验证。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20201012.
3
Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer.
坏死性凋亡关键调控基因的表达及其对非小细胞肺癌预后的影响。
J Cancer. 2020 Jul 11;11(18):5503-5510. doi: 10.7150/jca.46172. eCollection 2020.
4
Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.胰腺癌细胞中的程序性细胞坏死通过释放 CXCL5 促进癌细胞迁移和侵袭。
PLoS One. 2020 Jan 30;15(1):e0228015. doi: 10.1371/journal.pone.0228015. eCollection 2020.
5
Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis.半胱天冬酶-8 是细胞凋亡、坏死性凋亡和细胞焦亡的分子开关。
Nature. 2019 Nov;575(7784):683-687. doi: 10.1038/s41586-019-1770-6. Epub 2019 Nov 20.
6
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.肝癌中单免疫细胞的景观和动态。
Cell. 2019 Oct 31;179(4):829-845.e20. doi: 10.1016/j.cell.2019.10.003.
7
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.肿瘤内激活坏死性凋亡途径组件 RIPK1 和 RIPK3 增强抗肿瘤免疫。
Sci Immunol. 2019 Jun 21;4(36). doi: 10.1126/sciimmunol.aaw2004.
8
The role of necroptosis in cancer biology and therapy.细胞坏死性凋亡在癌症生物学和治疗中的作用。
Mol Cancer. 2019 May 23;18(1):100. doi: 10.1186/s12943-019-1029-8.
9
Complex roles of necroptosis in cancer.细胞程序性坏死在癌症中的复杂作用。
J Zhejiang Univ Sci B. 2019 May;20(5):399-413. doi: 10.1631/jzus.B1900160.
10
RIPK3-Mediated Necroptosis and Neutrophil Infiltration Are Associated with Poor Prognosis in Patients with Alcoholic Cirrhosis.RIPK3 介导的细胞坏死和中性粒细胞浸润与酒精性肝硬化患者的不良预后相关。
J Immunol Res. 2018 Nov 25;2018:1509851. doi: 10.1155/2018/1509851. eCollection 2018.